Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Regulatory News (SLN)

  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

6 Aug 2012 12:21

For filings with the FSA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer or the underlying issuer Silence Therapeuticsof existing shares to which voting rights are PLCattached:ii 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights x An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments An event changing the breakdown of voting rights Other (please specify): 3. Full name of person(s) subject to the ORA (Guernsey) Limitednotification obligation:iii 4. Full name of shareholder(s) (if different from 3.):iv 5. Date of the transaction and date on which the threshold is crossed or 2 August 2012reached: v 6. Date on which issuer notified: 6 August 2012 7. Threshold(s) that is/are crossed or 22%reached: vi, vii 8. Notified details: A: Voting rights attached to shares viii, ix Class/type of Situation previous Resulting situation after the triggering transactionshares to the triggering transaction if possible Number Number Number Number of voting % of voting using of of of shares rights rights x the ISIN CODE Shares Voting Rights Direct Direct xi Indirect Direct Indirect xii GB0008433350 Less than Less than 330,000,000 330,000,000 22.51% 3% 3% B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration Exercise/ Number of voting % of voting instrument date xiii Conversion Period xiv rights that may be rights acquired if the instrument is exercised/ converted. C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi Resulting situation after the triggering transaction Type of Exercise Expiration Exercise/ Number of voting rights % of voting financial price date xvii Conversion instrument refers to rights xix, xx instrument period xviii Nominal Delta Total (A+B+C) Number of voting rights Percentage of voting rights 330,000,000 22.51%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: 14. Contact name: Chris Hill 15. Contact telephone number: 01481 738724

Note: Annex should only be submitted to the FSA not the issuer Annex: Notification of major interests in sharesxxii A: Identity of the persons or legal entity subject to the notification obligation Full name (including legal form of legal entities) Contact address (registered office for legal entities) Phone number & email Other useful information (at least legal representative for legal persons)

B: Identity of the notifier, if applicable Full name Contact address Phone number & email Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) C: Additional information

For notes on how to complete form TR-1 please see the FSA website.

XLON
Date   Source Headline
24th Apr 20094:35 pmRNSPrice Monitoring Extension
1st Apr 20097:00 amPRNUnaudited Preliminary Results
30th Mar 200912:15 pmPRNNotice of Results
27th Mar 20094:40 pmRNSSecond Price Monitoring Extn
27th Mar 20094:35 pmRNSPrice Monitoring Extension
19th Mar 20091:22 pmPRNHolding(s) in Company
16th Feb 20093:37 pmPRNHolding(s) in Company
21st Jan 20097:00 amPRNStatement re Patent Update
19th Jan 20091:00 pmPRNHolding(s) in Company
15th Jan 20093:00 pmPRNTotal Voting Rights
15th Jan 20099:45 amPRNHolding(s) in Company
13th Jan 20094:36 pmRNSPrice Monitoring Extension
12th Jan 20097:00 amPRNStatement re Change of operating address
9th Jan 200911:20 amPRNStatement re Patent Grant
8th Jan 20092:21 pmPRNResearch Update
8th Jan 200912:03 pmPRNIssue of Equity
5th Jan 20094:40 pmRNSSecond Price Monitoring Extn
5th Jan 20094:35 pmRNSPrice Monitoring Extension
2nd Jan 20094:35 pmRNSPrice Monitoring Extension
31st Dec 200812:40 pmRNSSecond Price Monitoring Extn
31st Dec 200812:36 pmRNSPrice Monitoring Extension
31st Dec 20087:00 amPRNTotal Voting Rights
18th Dec 20084:35 pmRNSPrice Monitoring Extension
12th Dec 20084:40 pmRNSSecond Price Monitoring Extn
12th Dec 20084:36 pmRNSPrice Monitoring Extension
11th Dec 20087:10 amPRNHolding(s) in Company
10th Dec 20087:00 amPRNStatement re Patent Decision
5th Dec 200812:05 pmPRNIssue of Equity
4th Dec 20087:00 amPRNResearch Update
1st Dec 20087:00 amPRNResearch Update
18th Nov 20087:00 amPRNStatement re Patent Issue
13th Nov 20081:00 pmPRNHolding(s) in Company
10th Nov 20084:44 pmRNSSecond Price Monitoring Extn
10th Nov 20084:37 pmRNSPrice Monitoring Extension
29th Oct 200811:00 amPRNHolding(s) in Company
27th Oct 20089:45 amPRNDirector/PDMR Shareholding
22nd Oct 200812:51 pmPRNDirector/PDMR Shareholding
22nd Oct 20087:00 amPRNDirector/PDMR Shareholding
17th Oct 20083:34 pmPRNAGM Statement
8th Oct 200810:15 amPRNHolding(s) in Company
26th Sep 20085:05 pmPRNDirector/PDMR Shareholding
26th Sep 200811:55 amPRNStatement re Intellectual Property
25th Sep 20087:00 amPRNHalf-yearly Report
24th Sep 200811:40 amPRNHolding(s) in Company
29th Aug 200812:15 pmPRNHolding(s) in Company
26th Aug 20085:11 pmPRNHolding(s) in Company
7th Aug 20088:57 amPRNHolding(s) in Company
5th Aug 20082:00 pmPRNHolding(s) in Company
31st Jul 20087:00 amPRNStatement re Notice of Patent Allowance
30th Jul 20084:25 pmPRNStatement re Notice of Patent Allowance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.